FDA Approves Oral Form of ALS Drug Edaravone

FDA Approves Oral Form of ALS Drug Edaravone

The US Food and Drug Administration (FDA) has approved an orally administered version of edaravone (Radicava ORS) for adults with amyotrophic lateral sclerosis (ALS).  Edaravone is a pyrazolone free-radical scavenger thought to lessen the effects of oxidative stress, which is…

Read More